These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2274676)

  • 61. Role of cholecystokinin in mediating GRP-stimulated gastric, biliary and pancreatic functions in man.
    Hildebrand P; Drewe J; Luo H; Ketterer S; Gyr K; Beglinger C
    Regul Pept; 1992 Sep; 41(2):119-29. PubMed ID: 1438984
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients.
    Konturek JW; Konturek SJ; Domschke W
    Scand J Gastroenterol; 1995 Aug; 30(8):738-44. PubMed ID: 7481540
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Extrapancreatic cholinergic nerves mediate cholecystokinin-stimulated pancreatic polypeptide release.
    Kuvshinoff BW; Brodish RJ; Fink AS; McFadden DW
    J Surg Res; 1994 May; 56(5):397-401. PubMed ID: 8170138
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans.
    Zerbib F; Bruley Des Varannes S; Scarpignato C; Leray V; D'Amato M; Rozé C; Galmiche JP
    Am J Physiol; 1998 Dec; 275(6):G1266-73. PubMed ID: 9843762
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of cholecystokinin and of its antagonist, of atropine, and of food on the release of immunoglobulin A and immunoglobulin G specific antibodies in the rat intestine.
    Freier S; Eran M; Faber J
    Gastroenterology; 1987 Dec; 93(6):1242-6. PubMed ID: 3678742
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans.
    Schmidt WE; Schenk S; Nustede R; Holst JJ; Fölsch UR; Creutzfeldt W
    Gastroenterology; 1994 Dec; 107(6):1610-20. PubMed ID: 7958670
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of secretin and caerulein on pancreatic polypeptide and on insulin secretion from the isolated perfused ventral area of the rat pancreas.
    Funakoshi A; Miyazaki K; Nawata H
    Regul Pept; 1989 Jan; 24(1):111-6. PubMed ID: 2662263
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.
    Malesci A; De Fazio C; Festorazzi S; Bonato C; Valentini A; Tacconi M; Rovati L; Setnikar I
    Gastroenterology; 1990 May; 98(5 Pt 1):1307-10. PubMed ID: 2323521
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C; Varga G; Dobronyi I; Papp M
    Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of the cholecystokinin A receptor antagonist loxiglumide on the proliferation and cell cycle time of pancreatic acinar cells in rats.
    Kanemitsu D; Sakagami J; Motoyoshi T; Nakajima T; Kataoka K
    Pancreas; 2006 Mar; 32(2):190-6. PubMed ID: 16552340
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of CCK-receptor antagonist on colonic motor activity in dogs.
    Karaus M; Niederau C
    Neurogastroenterol Motil; 1995 Jun; 7(2):63-71. PubMed ID: 7621322
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cholecystokinin release by gastric distension--an atropine-sensitive mechanism.
    Koop I; Ruppert-Seipp G; Koop H; Schafmayer A; Arnold R
    Digestion; 1990; 46(4):220-7. PubMed ID: 2282997
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Physiological role of cholecystokinin in gastroprotection in humans.
    Konturek JW; Hengst K; Konturek SJ; Sito E; Stachura J; Domschke W
    Am J Gastroenterol; 1998 Dec; 93(12):2385-90. PubMed ID: 9860397
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of duodenal juice on bombesin-stimulated cholecystokinin release during loxiglumide administration in man.
    Jebbink MC; Jansen JB; van der Kleij FG; Mooy DM; Rovati LC; Lamers CB
    Eur J Clin Invest; 1993 Sep; 23(9):529-33. PubMed ID: 8243522
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Release of pancreatic polypeptide and its mechanism in luminal feedback regulation in the conscious rat.
    Miyasaka K; Funakoshi A; Miyazaki K; Kitani K
    Digestion; 1989; 43(1-2):73-80. PubMed ID: 2806758
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CCK receptor antagonist loxiglumide alters uptake of CCK in perfused liver and pancreatic acini of the rat.
    Beckh K; Göke R; Ruff W; Koop I; Arnold R; Adler G
    Digestion; 1991; 48(2):98-103. PubMed ID: 1868975
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog.
    Meyer FD; Gyr K; Häcki WH; Beglinger C; Jeker L; Varga L; Kayasseh L; Gillessen D; Stalder GA
    Gastroenterology; 1981 Apr; 80(4):742-7. PubMed ID: 7202946
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Physiological role and localization of cholecystokinin release in dogs.
    Konturek SJ; Tasler J; Bilski J; de Jong AJ; Jansen JB; Lamers CB
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G391-7. PubMed ID: 2870644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.